Stay updated with breaking news from Biomedical Engineering Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?
MIT Professor Amy Moran-Thomas teaches class 21A.311 (Social Lives of Medical Objects), an anthropology course that encourages students to envision more equitable device design.
Physician, scientist, and professor Richard J. Cohen has made influential contributions to the Harvard-MIT Program in Health Sciences and Technology since it began 50 years ago. He will transition to emeritus status in March.
Published: May 07, 2021 -Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY--(BUSINESS WIRE)-- Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are Robert S. Langer, an Institute Professor at MIT and the most cited...
Share this article Share this article GUILFORD, Conn. and NEW YORK, March 11, 2021 /PRNewswire/ -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), an innovative digital health company driving universal access to superior medical imaging, today announced the appointment of Stacey Pugh as Chief Commercial Officer, effective March 15 th. In this newly created executive position, Ms. Pugh will oversee the development and implementation of Butterfly's commercial strategy to ensure optimal value capture for Butterfly's unique imaging technology and clinical solutions. "Stacey is a highly ac...